🌐 Sustainability Strategy Framework
The sustainability strategy of PET Pharm Bio Co., Ltd. is anchored on four pillars: "Precision Medicine, Safe Drug Supply, Green Manufacturing, and Mutual Prosperity." Covering Environmental (E), Social (S), and Corporate Governance (G) dimensions and aligned with the United Nations Sustainable Development Goals (SDGs), we are committed to creating broader social and environmental value alongside business growth.
🌿
Environmental (E)
Energy Management · Radioactive Waste · Water Resources · Carbon Management
SDG 6SDG 7SDG 13
🤝
Social (S)
Occupational Health & Safety (Radiation Protection) · Talent Cultivation · Community Health
SDG 3SDG 4SDG 8
🏛️
Governance (G)
Corporate Governance · Business Integrity · Information Security · Supply Chain Management
SDG 16SDG 17
🤝 Stakeholder Engagement
The Company identifies key stakeholders and maintains effective communication through diverse channels:
- ▸
Shareholders & Investors — Annual General Meetings, Investor Conferences, Website Disclosures, Market Observation Post System (MOPS)
- ▸
Employees — Regular Staff Meetings, Satisfaction Surveys, Internal Training Programs, Grievance Channels
- ▸
Hospital & Healthcare Clients — Regular Visits, Quality Anomaly Notification System, Drug Recall Procedures
- ▸
Suppliers — Supplier Evaluation System, Corporate Social Responsibility Commitment Statements, Periodic Audits
- ▸
Regulatory Authorities — Periodic Filings with TFDA, AEC, and FSC; Annual Radiation Safety Inspections
- ▸
Academic & Research Institutions — Industry-Academia Collaboration, Technical Seminars, Joint R&D Projects
- ▸
Local Community — Environmental Safety Information Disclosures, Nearby Facility Environmental Monitoring Disclosures
⚖️ Material Topics
The Company conducts materiality assessments in accordance with GRI Standards. The following sustainability topics significantly impact PET Pharm Bio Co., Ltd. and its stakeholders:
💊 Pharmaceutical Quality & Patient Safety
Highest Priority
Highest Priority
☢️ Radiation Safety & Occupational Health
Highest Priority
Highest Priority
🏛️ Corporate Governance & Regulatory Compliance
👩🎓 Talent Cultivation & Retention
🚚 Responsible Supply Chain Management
🌱 GHG Emission Reduction
🔐 Information Security
🏆 Progress on Sustainability Goals
| ESG Dimension | Core Topic | Corresponding SDGs | 2024 Progress |
|---|---|---|---|
| Environmental (E) | GHG Management | SDG 13 | Initiated Scope 1/2 Inventory |
| Environmental (E) | Radioactive Waste Management | SDG 12 | 100% Recycling Rate |
| Social (S) | Occupational Safety & Health | SDG 8 | 0 Radiation Exceedance Incidents |
| Social (S) | Talent Cultivation | SDG 4 | Established Annual Training Plan |
| Governance (G) | Corporate Governance | SDG 16 | Completed Public Offering & Emerging Stock Registration |
| Governance (G) | Business Integrity | SDG 16 | 100% Integrity Statement Signing Rate |
🌱 GHG Inventory & Sustainability Promotion
I. Individual Company GHG Inventory and Assurance Execution Status
| Task Item | Scheduled Completion Date |
|---|---|
| Establish dedicated (or concurrent) units and personnel, along with their assigned responsibilities. | Completed in February 2025 |
| Complete individual company greenhouse gas inventory. | Expected Completion in Dec 2026 |
II. 2025 Sustainability Development Committee Activities
Fulfilling corporate social responsibility and employee care, the Company has actively participated in and executed economic, environmental, and social sustainability initiatives:
- ▸
(1) Participating in Blood Donation Campaigns — Demonstrating social care and promoting regular blood donation to fulfill public welfare values.
- ▸
(2) Attending Taiwan Stock Exchange "GHG Inventory - Border, Quantification, Reporting, and Assurance" Training Courses — Enhancing professional capabilities of dedicated personnel to accelerate greenhouse gas inventory goals.
- ▸
(3) Organizing Employee Routine Blood Examination Programs — Implementing workplace health management and employee care to protect staff rights and well-being.